Ipamorelin
Ipamorelin is a selective growth hormone secretagogue widely utilized in peptide research.
Investigators study its interaction with growth hormone pathways and its potential influence on
recovery and body composition. For laboratory research only.
$30.00
Research Use Disclaimer
These products are intended for laboratory research purposes only. They are not approved for human or veterinary use and are not intended to diagnose, treat, cure, or prevent any disease. Products should only be handled by qualified research professionals in appropriate laboratory settings.
Usage Restrictions
Laboratory Research Only
Provided exclusively for controlled in-vitro laboratory investigation.
Not for Human Consumption
Not approved for ingestion, injection, or any form of human or animal administration.
Not a Drug or Supplement
Not intended as a drug, dietary supplement, cosmetic, or medical treatment of any kind.
Qualified Researchers Only
Must be handled solely by trained professionals within a certified research environment.
SAFETY INFORMATION
Laboratory Handling
Wear appropriate PPE — gloves, laboratory coat, and eye protection at all times. Handle within a certified fume hood or biosafety cabinet where required. Avoid inhalation, skin contact, or contact with mucous membranes.
Storage Recommendations
Store lyophilized material at −20 °C, protected from light and moisture. Reconstituted solutions should be stored at 2–8 °C and used within 14 days. Avoid repeated freeze-thaw cycles to preserve structural integrity.
Safety Precautions
Consult the Safety Data Sheet (SDS) prior to handling. Do not consume, taste, or inhale. Treat all peptides as biologically active. In case of accidental exposure, flush with water and seek medical guidance.
Description
Ipamorelin is a selective growth hormone secretagogue widely utilized in peptide research.
Investigators study its interaction with growth hormone pathways and its potential influence on
recovery and body composition. For laboratory research only.
Reviews
There are no reviews yet.